2017 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013
DateTitle  
03/23/2017OpGen Announces 2016 Fourth Quarter and Year End Financial Results
Achieves Revenue of Approximately $4.0 Million, a 27% Year Over Year Increase GAITHERSBURG, Md., March 23, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the fourth quarter and year ended December 31, 2016 and summarized 2016 business highlights.  Total revenue for the full year ended December 31, 2016 was $4.0 million, a 27% increase from $3.2 million recorded for the full year ended December 31, 2015.  Net loss for the full year ended... 
 Printer Friendly Version
03/16/2017OpGen Announces Date of 2016 Fourth Quarter and Year End Financial Results Conference Call
GAITHERSBURG, Md., March 16, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it will report its 2016 fourth quarter and year end financial results after close of market Thursday, March 23, 2017. OpGen’s management team will host a live conference call and webcast at 4:30 p.m. Eastern Time to discuss the company’s financial results and recent developments. Dial-in Information U.S. Dial-In Number: 844-420-8185 International Dial-In Number: 216-562-0481 Conference ID... 
 Printer Friendly Version
03/01/2017OpGen to Present at the Cowen and Company 37th Annual Health Care Conference
GAITHERSBURG, Md., March 01, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that Evan Jones, the Company’s Chairman and Chief Executive Officer, will present a corporate overview at the Cowen and Company Health Care Conference on Tuesday, March 7, 2017 at 10:40 a.m. Eastern time. The conference is being held from March 6-8 in Boston, MA. To listen to the presentation live, investors may visit the investor relations section of OpGen, Inc.’s website at www.opgen.com. An ar... 
 Printer Friendly Version
02/14/2017OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting
Data support ability to predict antibiotic susceptibility in hours instead of days GAITHERSBURG, Md., Feb. 14, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced preliminary data demonstrating the ability to rapidly and accurately predict bacterial antibiotic susceptibility using resistance gene profiles. The data were presented at the Advances in Genome Biology and Technology (AGBT) meeting, which is taking place from February 13-16, 2017 in Hollywood Beach, FL. These prelimi... 
 Printer Friendly Version
01/26/2017OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results
Achieves Revenue of Approximately $4.0 Million, a 27% Year Over Year Increase GAITHERSBURG, Md., Jan. 26, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced preliminary unaudited results for the fourth quarter and full year ended December 31, 2016, and summarized 2016 business highlights.  Total revenue for the full year ended December 31, 2016 was approximately $4.0 million, a 27% increase from the $3.2 million recorded for the full year ended December 31, 2015. Total revenue... 
 Printer Friendly Version